Growing teratoma syndrome: Difference between revisions
CSV import |
CSV import |
||
| Line 37: | Line 37: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 13:48, 17 March 2025
Growing teratoma syndrome (GTS) is a rare condition that occurs in individuals who have been treated for germ cell tumors. The syndrome is characterized by an increase in the size of the tumor during or after chemotherapy, despite normal levels of tumor markers.
Etiology
The exact cause of growing teratoma syndrome is unknown. It is thought to occur when chemotherapy kills the malignant cells in a germ cell tumor, but leaves behind mature teratoma cells that continue to grow.
Symptoms
The symptoms of growing teratoma syndrome can vary depending on the location and size of the tumor. Common symptoms include abdominal pain, bloating, and a palpable mass. In some cases, the growing tumor can cause complications such as bowel obstruction or respiratory distress.
Diagnosis
Diagnosis of growing teratoma syndrome is based on clinical findings, imaging studies, and tumor marker levels. Imaging studies such as CT scan or MRI are used to detect an increase in the size of the tumor. Normal levels of tumor markers such as alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) in the presence of a growing tumor suggest the diagnosis of GTS.
Treatment
The primary treatment for growing teratoma syndrome is surgical removal of the tumor. In some cases, additional chemotherapy may be needed if malignant cells are found in the removed tumor.
Prognosis
The prognosis for individuals with growing teratoma syndrome is generally good if the entire tumor can be surgically removed. However, the condition can be life-threatening if the tumor causes serious complications or if malignant cells are found in the removed tumor.
See also
References
<references />


